Works matching AU Şendur, Mehmet

Results: 48
    1

    The relationship between adjuvant chemotherapy and thiol-disulfide compounds.

    Published in:
    Journal of Cancer Research & Therapeutics, 2022, v. 18, n. 4, p. 1114, doi. 10.4103/jcrt.JCRT_32_20
    By:
    • Akyol, Pınar;
    • Dede, Didem;
    • Bilgin, Burak;
    • Ulaş, Arife;
    • Nahit Şendur, Mehmet;
    • Akıncı, Muhammed;
    • Başer, Salih;
    • Erol, Cihan;
    • Hızal, Mutlu;
    • Yalçın, Bülent;
    • Dede, Didem Şener;
    • Nahit Şendur, Mehmet Ali;
    • Akıncı, Muhammed Bülent
    Publication type:
    Article
    2
    3

    Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.

    Published in:
    Oncologist, 2023, v. 28, n. 10, p. 875, doi. 10.1093/oncolo/oyad257
    By:
    • Ünal, Çağlar;
    • Azizy, Abdulmunir;
    • Karabulut, Senem;
    • Taştekin, Didem;
    • Akyıldız, Arif;
    • Yaşar, Serkan;
    • Yalçın, Şuayib;
    • Çoban, Eyüp;
    • Evrensel, Türkkan;
    • Kalkan, Ziya;
    • Oruç, Zeynep;
    • Derin, Sümeyra;
    • Turna, Zeynep Hande;
    • Bayram, Doğan;
    • Köş, Fahriye Tuğba;
    • Şendur, Mehmet Ali Nihat;
    • Sever, Nadiye;
    • Ercelep, Özlem;
    • Seyyar, Mustafa;
    • Kefeli, Umut
    Publication type:
    Article
    4
    5

    EILEEN STUDY: A RETROSPECTIVE REAL-WORLD ANALYSIS OF RESPONSE RATES WITH RIBOCICLIB AND ENDOCRINE THERAPY IN POSTMENOPAUSAL HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE METASTATIC BREAST CANCER.

    Published in:
    2024
    By:
    • Karaçin, Cengiz;
    • Başaran, Gül;
    • Kaplan, Muhammet Ali;
    • Göksu, Sema Sezgin;
    • Gümüş, Mahmut;
    • Inal, Ali;
    • Aksoy, Sercan;
    • Geredeli, Çağlayan;
    • Küçükzeybek, Yüksel;
    • Erdem, Dilek;
    • Gökmen, Erhan;
    • Harputluoğlu, Hakan;
    • Çilingiroğlu, Merve;
    • Gülkaya, Hayriye;
    • Uysal, Rana;
    • Nahit Şendur, Mehmet Ali
    Publication type:
    Abstract
    6

    Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer.

    Published in:
    Turkish Journal of Medical Sciences, 2025, v. 55, n. 3, p. 547, doi. 10.55730/1300-0144.6002
    By:
    • CEYLAN, Furkan;
    • ŞENER DEDE, Didem;
    • EFİL, Safa Can;
    • TENEKECİ, Ateş Kutay;
    • CEYLAN, Eren Göktuğ;
    • SEKMEK, Serhat;
    • ÇAKMAK, Mehmet;
    • BİLGİN, Burak;
    • YÜCEL, Şebnem;
    • TATLI DOĞAN, Hayriye;
    • ŞENDUR, Mehmet Ali Nahit;
    • AKINCI, Muhammed Bülent;
    • UNCU, Doğan;
    • YALÇIN, Bülent
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20056-3
    By:
    • Yücel, Kadriye Bir;
    • Yekedüz, Emre;
    • Karakaya, Serdar;
    • Tural, Deniz;
    • Ertürk, İsmail;
    • Erol, Cihan;
    • Ercelep, Özlem;
    • Öztaş, Nihan Şentürk;
    • Arslan, Çağatay;
    • Uçar, Gökhan;
    • Küçükarda, Ahmet;
    • Sever, Özlem Nuray;
    • Kılıçkap, Saadettin;
    • Can, Orçun;
    • Yazgan, Satı Coşkun;
    • Öksüzoğlu, Berna;
    • Karadurmuş, Nuri;
    • Şendur, Mehmet Ali;
    • Ürün, Yüksel
    Publication type:
    Article
    16

    Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.

    Published in:
    Urologia Internationalis, 2023, v. 107, n. 6, p. 595, doi. 10.1159/000528994
    By:
    • Erol, Cihan;
    • Yekedüz, Emre;
    • Tural, Deniz;
    • Karakaya, Serdar;
    • Şentürk Öztaş, Nihan;
    • Uçar, Gökhan;
    • Kılıçkap, Saadettin;
    • Ertürk, İsmail;
    • Sever, Özlem Nuray;
    • Arslan, Çağatay;
    • Küçükarda, Ahmet;
    • Can, Orçun;
    • Balvan, Özlem;
    • Yazgan, Satı Coşkun;
    • Özgüroğlu, Mustafa;
    • Öksüzoğlu, Berna;
    • Şendur, Mehmet Ali Nahit;
    • Ürün, Yüksel
    Publication type:
    Article
    17

    Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2023, v. 35, n. 2, p. 142, doi. 10.1080/1120009X.2022.2073159
    By:
    • Başoğlu, Tuğba;
    • Sakin, Abdullah;
    • Erol, Cihan;
    • Özden, Ercan;
    • Çabuk, Devrim;
    • Çılbır, Ebru;
    • Tataroğlu Özyükseler, Deniz;
    • Ayhan, Murat;
    • Şendur, Mehmet Ali;
    • Dogan, Mutlu;
    • Öksüzoğlu, Berna;
    • Eryılmaz, Melek Karakurt;
    • Er, Özlem;
    • Taşçı, Elif Şenocak;
    • Özyurt, Neslihan;
    • Dülgar, Özgecan;
    • Özen, Miraç;
    • Hacıbekiroğlu, İlhan;
    • Öner, İrem;
    • Bekmez, Esma Türkmen
    Publication type:
    Article
    18

    Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

    Published in:
    Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 3, p. 404, doi. 10.1177/10781552241241004
    By:
    • Yildirim, Mahmut Emre;
    • Karadurmuş, Nuri;
    • Ökten, İlker Nihat;
    • Türk, Hacı Mehmet;
    • Urakçı, Zuhat;
    • Arslan, Çağatay;
    • Çelik, Sinemis;
    • Dane, Faysal;
    • Şendur, Mehmet Ali Nahit;
    • Bilir, Cemil;
    • Karabulut, Bülent;
    • Cicin, İrfan;
    • Çubukçu, Erdem;
    • Karaca, Mustafa;
    • Ozcelik, Melike;
    • Artaç, Mehmet;
    • Tanrikulu, Eda;
    • Alacacioglu, Ahmet;
    • Açıkgöz, Özgür;
    • Öven, Başak
    Publication type:
    Article
    19
    20
    21

    The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3537, doi. 10.1007/s00432-022-04055-5
    By:
    • Yekedüz, Emre;
    • Tural, Deniz;
    • Ertürk, İsmail;
    • Karakaya, Serdar;
    • Erol, Cihan;
    • Ercelep, Özlem;
    • Arslan, Çağatay;
    • Sever, Özlem Nuray;
    • Kılıçkap, Saadettin;
    • Şentürk Öztaş, Nihan;
    • Küçükarda, Ahmet;
    • Can, Orçun;
    • Öksüzoğlu, Berna;
    • Şendur, Mehmet Ali;
    • Karadurmuş, Nuri;
    • Ürün, Yüksel
    Publication type:
    Article
    22
    23

    Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.

    Published in:
    European Journal of Clinical Pharmacology, 2022, v. 78, n. 12, p. 1973, doi. 10.1007/s00228-022-03403-1
    By:
    • Yekedüz, Emre;
    • Özbay, Mehmet Fatih;
    • Çağlayan, Dilek;
    • Yıldırım, Atila;
    • Erol, Cihan;
    • Yıldırım, Hasan Çağrı;
    • Tunç, Sezai;
    • Özyurt, Neslihan;
    • Özdemir, Feyyaz;
    • Şendur, Mehmet Ali Nahit;
    • Işıkdoğan, Abdurrahman;
    • Kılıçkap, Saadettin;
    • Ürün, Yüksel;
    • Yalçın, Şuayib;
    • Artaç, Mehmet;
    • Coşkun, Hasan Şenol;
    • Utkan, Güngör
    Publication type:
    Article
    24
    25

    Tamoxifen related chorioretinal structural changes.

    Published in:
    Cutaneous & Ocular Toxicology, 2023, v. 42, n. 3, p. 109, doi. 10.1080/15569527.2023.2220388
    By:
    • Erbahçeci Timur, İnci Elif;
    • Açıkgöz, Vehbi;
    • Uğurlu, Nagihan;
    • Yalçın, Bülent;
    • Şendur, Mehmet Ali Nahit;
    • Hızal, Mutlu;
    • Kara, Halil
    Publication type:
    Article
    26

    Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study.

    Published in:
    Medicina (1010660X), 2025, v. 61, n. 5, p. 776, doi. 10.3390/medicina61050776
    By:
    • Ceylan, Furkan;
    • Aktürk Esen, Selin;
    • Ünal, Olçun Ümit;
    • Aslan, Ferit;
    • Onur, İlknur Deliktaş;
    • Ateş, Öztürk;
    • Demirciler, Erkut;
    • Ünek, İlkay Tuğba;
    • Gülmez, Ahmet;
    • Özen Engin, Esra;
    • Taş, Semra;
    • Gököz Doğu, Gamze;
    • Şimşek, Melih;
    • Türk, Hacı Mehmet;
    • İnal, Ali;
    • Şahin, Gökhan;
    • Yüksel, Haydar Çağatay;
    • Tenekeci, Ateş Kutay;
    • Hızal, Mutlu;
    • Şendur, Mehmet Ali Nahit
    Publication type:
    Article
    27
    28
    29

    Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251331540
    By:
    • Aykan, Musa Barış;
    • Bölek, Hatice;
    • Yekedüz, Emre;
    • Sertesen, Elif;
    • Tural, Deniz;
    • Karaçin, Cengiz;
    • Şendur, Mehmet Ali Nahit;
    • Uçar, Gökhan;
    • Arslan, Çağatay;
    • Işık, Selver;
    • Sim, Saadet;
    • Sever, Özlem Nuray;
    • Hacıoğlu, Bekir;
    • Sezgin Göksu, Sema;
    • Özgüroğlu, Mustafa;
    • Karadurmuş, Nuri;
    • Ürün, Yüksel
    Publication type:
    Article
    30
    31

    Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 8, p. 1506, doi. 10.1007/s10147-021-01936-6
    By:
    • Tural, Deniz;
    • Ölmez, Ömer Fatih;
    • Sümbül, Ahmet Taner;
    • Özhan, Nail;
    • Çakar, Burcu;
    • Köstek, Osman;
    • Ekenel, Meltem;
    • Erman, Mustafa;
    • Coşkun, Hasan Şenol;
    • Selçukbiricik, Fatih;
    • Keskin, Özge;
    • Türköz, Fatma Paksoy;
    • Oruç, Kerem;
    • Bayram, Selami;
    • Bilgetekin, İrem;
    • Yıldız, Birol;
    • Şendur, Mehmet Ali Nahit;
    • Paksoy, Nail;
    • Dirican, Ahmet;
    • Erdem, Dilek
    Publication type:
    Article
    32
    33

    The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study.

    Published in:
    International Journal of Colorectal Disease, 2021, v. 36, n. 6, p. 1311, doi. 10.1007/s00384-021-03888-9
    By:
    • Akdeniz, Nadiye;
    • Kaplan, Muhammet Ali;
    • Uncu, Doğan;
    • İnanç, Mevlüde;
    • Kaya, Serap;
    • Dane, Faysal;
    • Küçüköner, Mehmet;
    • Demirci, Ayşe;
    • Bilici, Mehmet;
    • Durnalı, Ayşe Gök;
    • Koral, Lokman;
    • Şendur, Mehmet Ali Nahit;
    • Erol, Cihan;
    • Türkmen, Esma;
    • Ölmez, Ömer Fatih;
    • Açıkgöz, Özgür;
    • Laçin, Şahin;
    • Şahinli, Hayriye;
    • Urakçı, Zuhat;
    • Işıkdoğan, Abdurrahman
    Publication type:
    Article
    34

    Understanding of Clinical Trials Among Patients With Cancer and Their Relatives.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 1, p. e2457020, doi. 10.1001/jamanetworkopen.2024.57020
    By:
    • Kubilay Tolunay, Pınar;
    • Erol, Cihan;
    • Kahraman, Seda;
    • Yıldız Tacar, Seher;
    • Özcan, Erkan;
    • Buğdaycı Başal, Fatma;
    • Köse, Fatih;
    • Şendur, Mehmet Ali Nahit;
    • Tural, Deniz;
    • Çiçin, İrfan;
    • Öksüzoğlu, Berna;
    • Kılıçkap, Saadettin;
    • Ürün, Yüksel
    Publication type:
    Article
    35
    36
    37

    Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach †.

    Published in:
    Cancers, 2025, v. 17, n. 2, p. 233, doi. 10.3390/cancers17020233
    By:
    • Bozcuk, Hakan Şat;
    • Sert, Leyla;
    • Kaplan, Muhammet Ali;
    • Tatlı, Ali Murat;
    • Karaca, Mustafa;
    • Muğlu, Harun;
    • Bilici, Ahmet;
    • Kılıçtaş, Bilge Şah;
    • Artaç, Mehmet;
    • Erel, Pınar;
    • Yumuk, Perran Fulden;
    • Bilgin, Burak;
    • Şendur, Mehmet Ali Nahit;
    • Kılıçkap, Saadettin;
    • Taban, Hakan;
    • Ballı, Sevinç;
    • Demirkazık, Ahmet;
    • Akdağ, Fatma;
    • Hacıbekiroğlu, İlhan;
    • Güzel, Halil Göksel
    Publication type:
    Article
    38

    Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes.

    Published in:
    Cancers, 2024, v. 16, n. 22, p. 3880, doi. 10.3390/cancers16223880
    By:
    • Ozbay, Mehmet Fatih;
    • Harputluoglu, Hakan;
    • Karaca, Mustafa;
    • Tekin, Omer;
    • Şendur, Mehmet Ali Nahit;
    • Kaplan, Muhammed Ali;
    • Sahin, Berksoy;
    • Geredeli, Caglayan;
    • Teker, Fatih;
    • Tural, Deniz;
    • Saglam, Sezer;
    • Çil, Timuçin;
    • Bilici, Ahmet;
    • Erol, Cihan;
    • Kalkan, Ziya;
    • Bayram, Ertugrul;
    • Selvi, Oguzhan;
    • Gültürk, İlkay;
    • Göksu, Sema Sezgin;
    • Tatlı, Ali Murat
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Treatment Patterns and Attrition in Metastatic Renal Cell Carcinoma: Real-Life Experience from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 1, p. N.PAG, doi. 10.1016/j.clgc.2024.102282
    By:
    • Bölek, Hatice;
    • Sertesen, Elif;
    • Kuzu, Omer Faruk;
    • Tural, Deniz;
    • Sim, Saadet;
    • Nahit Şendur, Mehmet Ali;
    • Uçar, Gökhan;
    • Işık, Selver;
    • Hacıoğlu, Bekir;
    • Çiçin, İrfan;
    • Arslan, Çağatay;
    • Göksu, Sema Sezgin;
    • Sever, Özlem Nuray;
    • Karaçin, Cengiz;
    • Karadurmuş, Nuri;
    • Özgüroğlu, Mustafa;
    • Yekedüz, Emre;
    • Ürün, Yüksel
    Publication type:
    Article
    45

    Outcomes by Retrospective Eligibility for Maintenance Therapy of Patients With Advanced Urothelial Carcinoma: Post Hoc Analysis of the Phase 3 KEYNOTE-361 Trial.

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 1, p. N.PAG, doi. 10.1016/j.clgc.2024.102248
    By:
    • Mamtani, Ronac;
    • Matsubara, Nobuaki;
    • Pino, Alvaro Montesa;
    • Herranz, Urbano Anido;
    • Şendur, Mehmet A． N.;
    • Gravis, Gwenaelle;
    • Huillard, Olivier;
    • Lee, Hyo Jin;
    • Gafanov, Rustem;
    • Joly, Florence;
    • Bedke, Jens;
    • Sella, Avishay;
    • Chang, Yen-Hwa;
    • Imai, Kentaro;
    • Moreno, Blanca Homet;
    • Xu, Jin Zhi;
    • Alva, Ajjai;
    • Powles, Thomas
    Publication type:
    Article
    46

    External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database

    Published in:
    Clinical Genitourinary Cancer, 2023, v. 21, n. 1, p. 175, doi. 10.1016/j.clgc.2022.07.006
    By:
    • Yekedüz, Emre;
    • Karakaya, Serdar;
    • Ertürk, İsmail;
    • Tural, Deniz;
    • Uçar, Gökhan;
    • Öztaş, Nihan Şentürk;
    • Arıkan, Rukiye;
    • Hızal, Mutlu;
    • Küçükarda, Ahmet;
    • Sever, Özlem Nuray;
    • Arslan, Çağatay;
    • Can, Orçun;
    • Kılıçkap, Saadettin;
    • Yazgan, Coşkun;
    • Karadurmuş, Nuri;
    • Şendur, Mehmet Ali;
    • Çiçin, İrfan;
    • Demirci, Umut;
    • Özgüroğlu, Mustafa;
    • Öksüzoğlu, Berna
    Publication type:
    Article
    47
    48